| Literature DB >> 31034584 |
Silvia Tonon1, Francesca Mion1, Jun Dong2, Hyun-Dong Chang2, Emiliano Dalla1, Patrizia Scapini3, Giuseppe Perruolo4, Andrea Zanello1, Matteo Dugo5, Marco A Cassatella3, Mario P Colombo6, Andreas Radbruch2, Claudio Tripodo7, Carlo E Pucillo1.
Abstract
Among the family of regulatory B cells, the subset able to produce interleukin-10 (IL-10) is the most studied, yet its biology is still a matter of investigation. The DNA methylation profiling of the il-10 gene locus revealed a novel epigenetic signature characterizing murine B cells ready to respond through IL-10 synthesis: a demethylated region located 4.5 kb from the transcription starting site (TSS), that we named early IL10 regulatory region (eIL10rr). This feature allows to distinguish B cells that are immediately prone and developmentally committed to IL-10 production from those that require a persistent stimulation to exert an IL-10-mediated regulatory function. These late IL-10 producers are instead characterized by a delayed IL10 regulatory region (dIL10rr), a partially demethylated DNA portion located 9 kb upstream from the TSS. A demethylated region was also found in human IL-10-producing B cells and, very interestingly, in some B-cell malignancies, such as chronic lymphocytic leukemia and mantle cell lymphoma, characterized by an immunosuppressive microenvironment. Our findings define murine and human regulatory B cells as an epigenetically controlled functional state of mature B cell subsets and open a new perspective on IL-10 regulation in B cells in homeostasis and disease.Entities:
Keywords: B cells; B-cell malignancies; DNA methylation; Interleukin 10; epigenetics
Mesh:
Substances:
Year: 2019 PMID: 31034584 DOI: 10.1002/eji.201848025
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532